Odyssey at Pondering Blather discusses his distaste for data-mining bioinformatics talks and poster presentations. The underlying issue, the blogger suggests, is that many bioinformatics-based projects suffer from "a lack of imagination and a disconnection from the underlying biology." This could be partly because the field is "still at a stage where method development trumps method application," Odyssey says.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.